SLC2A1 and cancer: A prominent characteristic of cancer is altered metabolism (Pavlova et al., 2022) and GLUT1 is aberrantly expressed in various cancers, including lung cancer, brain cancer, breast cancer, and bladder cancer (Ganapathy et al., 2009; Macheda et al., 2005).